Verona Pharma is a biopharmaceutical company dedicated to developing and commercializing innovative treatments for chronic respiratory diseases. The company has achieved FDA approval for its first product and is advancing a pipeline that includes therapies for conditions such as non-CF bronchiectasis, cystic fibrosis, and asthma. Verona Pharma's mission is to enhance the lives of patients navigating progressive respiratory conditions through cutting-edge drug development. Emphasizing collaboration, diversity, and inclusivity, Verona fosters a culture where employees are encouraged to contribute towards a healthier future for patients globally.